Tech Company Financing Transactions

Xanodyne Pharmaceuticals Funding Round

MPM Capital, Aisling Capital and Blue Chip Venture Company participated in a $38 million funding round for Xanodyne Pharmaceuticals. The round was announced on 6/4/2009.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

One Riverfront Place
Newport, KY 41071
USA

Phone

(859) 371-6383

Website

www.xanodyne.com

Email Address

[email protected]

Overview

Xanodyne is a specialty pharmaceutical company with commercial and development capabilities for providing better patient care in women's health and pain management.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Natasha Giordano

        

Chief Financial Officer

Rita O'Connor

        

Chief Operating Officer

Fabrice Egros

        

VP - Regulatory Affairs

Thomas Jennings

        

Browse more venture capital transactions:

Prev: 6/4/2009: Active Implants venture capital transaction
Next: 6/4/2009: Mimosa Systems venture capital transaction

Share this article

Where The Data Comes From

We do our best to document tech company VC transactions. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary